ITBT & AI Pharma Forum: Shaping the Future of Intelligent Drug Discovery

ITBT is a novel concept derived from artificial intelligence and big data, representing an organic integration of Information Technology (IT) and Biotechnology (BT), with a focus on biopharmaceutical development driven by big data algorithms. ITBT has emerged as one of the hottest sectors in the biopharmaceutical industry. The convergence of IT and BT technologies has unlocked limitless possibilities, among which AI-driven drug discovery stands out as the most significant and extensive intersection. By leveraging biological data processed through information technology, this approach accelerates drug R&D while enhancing drug quality, ultimately aiming to deliver high-quality novel drugs and vaccines in a shorter timeframe.

Hosted by the 7th Future Healthcare Top 100 Conference and supported by Wuyuan Capital, the ITBT & AI Drug Discovery Forum delves into hot topics in AI-driven drug development and related interdisciplinary fields from an ITBT perspective. Through sharing and dialogue among leading enterprises and seasoned investors, the forum aims to identify key breakthroughs in the industry, present a clearer roadmap for industrial development, and promote the further advancement of the ITBT sector.

2023 Future Healthcare Top 100 Conference, hosted by VB100, VCBeat, and Eggshell Research Institute, with strategic partnership support from Shanghai Zhangjiang Group, will be grandly held at the Shanghai Zhangjiang Science Hall from May 5–7, 2023. Led by Academician Robert Langer and IEEE scientists, nearly 500 industry leaders will convene for three main forums and 31 hot-topic sessions!